Thomas Schinecker - CEO of Roche | Podcast | In Good Company | Norges Bank Investment Management

(51:26)

Roche's weight loss adjacent drugs will boost its competitiveness, CEO says

(3:57)

The U.S.' Inflation Reduction Act risks hampering innovation, says Roche CEO

(1:53)

Roche CEO says there is strong underlying growth in our business

(3:8)

Roche Has Over Five Weight-Loss Companion Medicines, CEO Says

(7:7)

The Future of Cancer Treatment - Thomas Schinecker | Highlights | In Good Company

(10:6)

Roche CEO on pharma business: 'We have one of the strongest pipelines in the industry'

(3:5)

Roche Diagnostics CEO: GenMark deal will further expand global reach

(3:28)

The Future of Diagnostics

(25:15)

Are you really worth a CHF 15 million salary, Mr. Schwan?

(26:17)

How has global pharma company Roche grown with Singapore in the last 50 years?

(1:43)

Roche Diagnostics CEO: New rapid test designed to detect Covid-19 super spreaders

(4:54)

New biomarkers, technologies and pharma products will fill Covid vacuum: Roche CEO

(3:26)

Roche-CEO: \

(2:39)

Why is #america better than #europe? Schroders #CEO answers in this #podcast

(11)

Ep. 130 - Steady as a Roche. Plus: Washington Turbulence

(19:54)

Roche-CEO: Zu Grunde liegendes Wachstum war stark

(3:40)

Pharma Giant Delays Cancer Treatment Drug To Punish Biden

(5:1econd)

Overall we achieved good results, delivered on our numbers and targets: Roche CEO

(2:18)

Legalese Decoder acquisition Related News Sat, 09 Sep 2023 23:13:02 +0000

(16)